Search Results

Significant prognostic value of cell-cycle proteins in early-stage small cell carcinoma of cervix.

• Authors : Xu, Qing¹ (AUTHOR); Zhou, Hongyu^2,3 (AUTHOR); Wu, Jiao^2,3 (AUTHOR)

• Source: Scientific Reports. 7/24/2025, Issue 1, p1-11. 11p.

Record details

Cell cycle proteins: Linking the cell cycle to tumors

• Authors : JIE ZHONG; JUE LIU; XING TANG

• Source: Oncology Research. 0:1-10

Record details

miR-29c-3p downregulation accelerates spinal cord injury progression by targeting BRD4.

• Authors : Wang D; Department of Orthopedics, Zhangjiakou First Hospital, No. 6 Libaisi Lane, Qiaoxi District, Zhangjiakou City, Hebei Province, 075000, China. .; Wang X

Subjects: Spinal Cord Injuries*/Spinal Cord Injuries*/Spinal Cord Injuries*/genetics ; Spinal Cord Injuries*/Spinal Cord Injuries*/Spinal Cord Injuries*/blood ; Spinal Cord Injuries*/Spinal Cord Injuries*/Spinal Cord Injuries*/diagnosis

• Source: Journal of orthopaedic surgery and research [J Orthop Surg Res] 2025 Jul 25; Vol. 20 (1), pp. 703. Date of Electronic Publication: 2025 Jul 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101265112 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-799X

Record details

SPC25 as a prognostic and immune-related biomarker in lung adenocarcinoma.

• Authors : Liu P; Laboratory of Basic Medicine, General Hospital of Northern Theater Command, Shenyang, 110016, Liaoning, China.; Beifang Hospital of China Medical University, Shenyang, China.

Subjects: Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/immunology ; Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/genetics ; Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/pathology

• Source: Scientific reports [Sci Rep] 2025 Jul 21; Vol. 15 (1), pp. 26414. Date of Electronic Publication: 2025 Jul 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

CCNY-mediated phosphorylation and TET2-BACH1-driven DNA demethylation activate PRC1 to augment NSCLC progression.

• Authors : Huang D; Department of Thoracic Surgery, Huashan Hospital of Fudan University, Shanghai, 200040, P.R. China.; Chu X

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/metabolism

• Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2025 Jul 15; Vol. 44 (1), pp. 206. Date of Electronic Publication: 2025 Jul 15.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

Record details

TEAD4 Transcriptionally Activates TRIB3 to Induce Ferroptosis Resistance through the MEK/ERK Signaling Pathway in Colorectal Cancer.

• Authors : Wang J; Department of General Surgery, The Second People's Hospital of China Three Gorges University, Yichang, China.; Wu X

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/genetics ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/genetics ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/metabolism

• Source: Gut and liver [Gut Liver] 2025 Jul 15; Vol. 19 (4), pp. 579-591. Date of Electronic Publication: 2025 Apr 01.Publisher: Editorial Office of Gut and Liver Country of Publication: Korea (South) NLM ID: 101316452 Publication Model: Print-Electronic Cited Medium:

Record details

TTK activates ATR through RPA2 phosphorylation to promote olaparib resistance in ovarian cancer.

• Authors : Qi G; Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, China.; Gynecologic Oncology Key Laboratory of Shandong Province, Qilu Hospital, Shandong University, Jinan, China.

Subjects: Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/metabolism ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics

• Source: Communications biology [Commun Biol] 2025 Jul 05; Vol. 8 (1), pp. 1011. Date of Electronic Publication: 2025 Jul 05.Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

An orally bioavailable BRD4 inhibitor disrupts expansion of a pathogenic epithelial-mesenchymal niche in bleomycin-induced fibrosis.

• Authors : Skibba M; Department of Medicine, School of Medicine and Public Health, University of Wisconsin Madison, Madison, WI, USA.; Ma Z

Subjects: Bleomycin*/Bleomycin*/Bleomycin*/toxicity ; Transcription Factors*/Transcription Factors*/Transcription Factors*/antagonists & inhibitors ; Transcription Factors*/Transcription Factors*/Transcription Factors*/metabolism

• Source: Respiratory research [Respir Res] 2025 Jul 02; Vol. 26 (1), pp. 221. Date of Electronic Publication: 2025 Jul 02.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Inactivation of Histone Chaperone HIRA Unmasks a Link Between Normal Embryonic Development of Melanoblasts and Maintenance of Adult Melanocyte Stem Cells.

• Authors : Jaber-Hijazi F; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; CRUK Scotland Institute, Glasgow, UK.

Subjects: Melanocytes*/Melanocytes*/Melanocytes*/metabolism ; Melanocytes*/Melanocytes*/Melanocytes*/cytology ; Histone Chaperones*/Histone Chaperones*/Histone Chaperones*/metabolism

• Source: Aging cell [Aging Cell] 2025 Jul; Vol. 24 (7), pp. e70070. Date of Electronic Publication: 2025 May 14.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101130839 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

BRD4 acts as a transcriptional repressor of RhoB to inhibit terminal erythropoiesis.

• Authors : Chen Y; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, 310058, China.; Institute of Hematology, Zhejiang University, Hangzhou, 310058, China.

Subjects: Erythropoiesis*/Erythropoiesis*/Erythropoiesis*/genetics ; Transcription Factors*/Transcription Factors*/Transcription Factors*/metabolism ; Transcription Factors*/Transcription Factors*/Transcription Factors*/antagonists & inhibitors

• Source: Journal of hematology & oncology [J Hematol Oncol] 2025 Jul 01; Vol. 18 (1), pp. 67. Date of Electronic Publication: 2025 Jul 01.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

Record details